Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,727.44
+14.660.86%
Number of Gainers:5
Number of Losers:2
Number of Flat:- -
PE:- -
High:1,745.93
Open:1,710.27
Low:1,697.28
Close:1,712.79
Volume:60.92M
Turnover:5.75B
Market Cap:1.80T
Float Cap:1.73T

Loading ...

OverviewNews

Altimmune Inc Expected to Post a Loss of 14 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

Novo Nordisk, Amazon Web Services Collaborate to Advance Drug Discovery for Chronic Diseases

MT Newswires Live
·
Aug 10

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), Vanda (VNDA) and AbCellera Biologics (ABCL)

TIPRANKS
·
Aug 10

UK Green Lights Lilly's Obesity Pill

Reuters
·
Aug 10

UK’s MHRA Authorises Orforglipron for Weight Management and Type 2 Diabetes

Reuters
·
Aug 10

Sino Biopharmaceutical Stock Sheds 0.9% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 10

Analysts Conflicted on These Healthcare Names: Evolent Health (EVH), Eli Lilly & Co (LLY) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Aug 10

Amgen Inc : HSBC Raises Target Price to $445 from $425

THOMSON REUTERS
·
Aug 10

Nvidia, Eli Lilly, and Disney Show It's Time to Back the Top Dogs

Dow Jones
·
Aug 10

Pfizer Stock Leads 3 AI Healthcare Picks Built For Smarter Care

Simply Wall St.
·
Aug 09

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.